We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Out of focus

12 July 2013 By Una Galani

Tapping investors to cut debt and expand its medical unit makes sense for the scandal-hit Japanese company. But only selling shares overseas is a slight on local shareholders who endured the dark days. Besides, a close-up view suggests Olympus’s finances were already on the mend.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)